Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage

Arthritis and Rheumatism

Volumn 58, Issue 11, 2008, Pages 3520-3529

  Namdari, Surena ^a   Wei, Lei ^a   Moore, Douglas ^a   Chen, Qian ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BIOMECHANICS; CELL PROTECTION; CONTROLLED STUDY; FEMALE; FEMUR; GENE INACTIVATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; LEG LENGTH; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIBIA; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CARTILAGE; CHONDROCYTES; EXTREMITIES; MICE; MICE, TRANSGENIC; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSGENES;

EID: 55849133703     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.23999     Document Type: Article

References (50)

1. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 2001;268: 6058-65.
2. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem 2001;276:46707-13.
3. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994;78:1027-37.
4. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-6.
5. Wei L, Chen Q. Regulation of chondrocyte death during endochondral ossification by p38 mitogen-activated protein kinase: mechanism of coupling hypertrophy and apoptosis. Transactions of the 47th Annual Meeting of the Orthopaedic Research Society. Rosemont (IL): Orthopaedic Research Society; 2001, vol. 26, no. 0329.
6. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TF, Taylor DJ, et al. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 1997; 158:3165-73.
7. Ravanti L, Heino J, Lopez-Otin C, Kahari VM. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1999;274;2446-55.
8. Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, et al. Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999;274:37292-300.
9. Simon C, Goepfert H, Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 1998;58:1135-9.
10. Adams JL, Badger AM, Kumar S, Lee JC. P38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 2001;38:1-60.
11. Dai SM, Shan ZZ, Nakamura H, Masuko-Hongo K, Kato T, Nishioka K, et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 2006; 54:818-31.
12. Wei L, Sun X, Wang Z, Chen Q. CD95-induced osteoarthritic chondrocyte apoptosis and necrosis: dependency on p38 mitogen-activated protein kinase. Arthritis Res Ther 2006;8:R37.
13. 2 and nitric oxide in chondrogenically differentiated mesenchymal progenitor cells. Osteoarthritis Cartilage 2006;14:460-70.
14. 2 production in human chondrocytes. Int Immunopharmacol 2006;6:144-55.
15. Ea HK, Uzan B, Rey C, Liote F. Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes. Arthritis Res Ther 2005;7:R915-26.
16. Boileau C, Pelletier JP, Tardif G, Fahmi H, Laufer S, Lavigne M, et al. The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway. Ann Rheum Dis 2005;64:891-8.
17. Malemud CJ. Protein kinases in chondrocyte signaling and osteoarthritis. Clin Orthop Relat Res 2004;427 Suppl:S145-51.
18. Masuko-Hongo K, Berenbaum F, Humbert L, Salvat C, Goldring MB, Thirion S. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum 2004;50: 2829-38.
19. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. Mitogen-activated protein kinase and nuclear factor -B together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum 1999;42:2399-409.
20. Iwasa H, Han J, Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003;8:131-44.
21. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 2005; 175:8296-302.
22. Yudoh K, Nakamura H, Masuko-Hongo K, Kato T, Nishioka K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1α in articular chondrocytes: involvement of HIF-1α in the pathogenesis of osteoarthritis. Arthritis Res Ther 2005;7:R904-14.
23. Kim HA, Lee KB, Bae SC. The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death. Arthritis Res Ther 2005;7:R526-35.
24. Zhen X, Wei L, Wu Q, Zhang Y, Chen Q. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem 2001;276:4879-85.
25. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 2004;16:616-22.
26. Nguyen J, Gogusev J, Knapnougel P, Bauvois B. Protein tyrosine kinase and p38 MAPK pathways involved in stimulation of matrix metalloproteinase-9 by TNF-α in human monocytes. Immunol Lett 2006;106:34-41.
27. Seto H, Kamekura S, Miura T, Yamamoto A, Chikuda H, Ogata T, et al. Distinct roles of SMAD pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J Clin Invest 2004;113:718-26.
28. 2 via ATP in articular chondrocytes. J Biol Chem 2003;278:13680-7.
29. Weston AD, Sampaio AV, Ridgeway AG, Underhill TM. Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J Cell Sci 2003;116:2885-93.
30. Maroni PD, Koul S, Meacham RB, Koul HK. Mitogen activated protein kinase signal transduction pathways in the prostate [review]. Cell Commun Signal 2004;2:5.
31. Robbins JR, Thomas B, Tan L, Choy B, Arbiser JL, Berenbaum F, et al. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1β. Arthritis Rheum 2000;43:2189-201.
32. Alessi DR, Ceunda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270: 27489-94.
33. Murakami S, Kan M, McKeehan WL, de Crombrugghe B. Upregulation of the chondrogenic sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 2000;91:1113-8.
34. Yonekura A, Osaki M, Hirota Y, Tsukazaki T, Miyazaki Y, Matsumoto T, et al. Transforming growth factor-β stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocr J 1999;46:545-53.
35. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 1999;250:351-63.
36. Thomas B, Thirion S, Humbert L, Tan L, Goldring MB, Bereziat G, et al. Differentiation regulates interleukin-1β-induced cyclooxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase. Biochem J 2002;362(Pt 2):367-73.
37. Kang S, Jung M, Kim CW, Shin DY. Inactivation of p38 kinase delays the onset of senescence in rabbit articular chondrocytes. Mech Ageing Dev 2005;126:591-7.
38. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated downregulation of Wnt-7a pathway. Mol Cells 2006;22:353-9.
39. Enslen H, Brancho DM, Davis RJ. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J 2000;19:1301-11.
40. Sun X, Wei L, Cheah K, Bronson S, Chen Q. Abolition of endochondral bone formation by a dominant negative p38 MAP kinase transgene in a transgenic mouse model. Transactions of the 49th Annual Meeting of the Orthopaedic Research Society. Rosemont (IL): Orthopaedic Research Society; 2003, vol. 28, no. 0341.
41. Cheah KS, Levy A, Trainor PA, Wai AW, Kuffner T, So CL, et al. Human COL2A1-directed SV40 T antigen expression in transgenic and chimeric mice results in abnormal skeletal development. J Cell Biol 1995;128:223-37.
42. Hiltunen A, Vuorio E, Aro HT. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993;11:305-12.
43. Jamsa T, Jalovaara P, Peng Z, Vaananen HK, Tuukkanen J. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 1998;23:155-61.
44. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone 1993;14:595-608.
45. Maier I, Wilhelmi G. Osteoarthrosis-like disease in mice: effects of anti-arthrotic and anti-rheumatic agents. In: Lott DJ, Jasani MK, Birdwood GF, editors. Studies in osteoarthrosis: pathogenesis, intervention and assessment. Chichester (UK): John Wiley & Sons; 1987. p. 75-83.
46. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 2000;191: 859-70.
47. Murata M, Yudoh K, Nakamura H, Kato T, Inoue K, Chiba J, et al. Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. J Orthop Res 2006;24:1544-54.
48. Lim YB, Kang SS, An WG, Lee YS, Chun JS, Sonn JK. Chondrogenesis induced by actin cytoskeleton disruption is regulated via protein kinase C-dependent p38 mitogen-activated protein kinase signaling. J Cell Biochem 2003;88:713-8.
49. Radons J, Bosserhoff AK, Grassel S, Falk W, Schubert TE. p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med 2006;17: 661-8.
50. Ulivi V, Tutolo G, Mallein-Gerin F, Daga A, Cancedda R, Cancedda FD. A common pathway in differentiation and inflammation: p38 mediates expression of the acute phase SIP24 iron binding lipocalin in chondrocytes. J Cell Physiol 2006;206:728-37.